Blood Cancer Discovery | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 4,

Issue 5

1 September 2023

About the Journal

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More About the Journal

Editors-in-Chief

Riccardo Dalla-Favera
Kenneth C. Anderson

View Full Editorial Board

Impact Factor

11.2

SUBMIT TO JOURNAL

Featured Articles

Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel

Bruno Paiva, et al.

HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion

Kosuke Toyoda, et al.

A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML

Lanpeng Chen , et al.

Trending - Altmetric

The article titled, The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms, has an Alt Metric Attention Score of 63.05. Click to see more of this article's metrics.

Read the article titled, The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms

Last mentioned on Thursday September 21 2023

The article titled, T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies, has an Alt Metric Attention Score of 40.7. Click to see more of this article's metrics.

Read the article titled, T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies

Last mentioned on Saturday September 16 2023

The article titled, Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches, has an Alt Metric Attention Score of 3.25. Click to see more of this article's metrics.

Read the article titled, Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches

Last mentioned on Friday September 15 2023

The article titled, Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy, has an Alt Metric Attention Score of 1. Click to see more of this article's metrics.

Read the article titled, Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

Last mentioned on Friday September 15 2023

The article titled, MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma, has an Alt Metric Attention Score of 19.6. Click to see more of this article's metrics.

Read the article titled, MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma

Last mentioned on Thursday September 14 2023

Latest
Most Read
Most Cited

AACR Cancer Centers Alliance: Fostering Collaboration and Innovation to Advance Lifesaving Scientific Discoveries for Patients

Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML

HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion

The Twitter live feed is not currently active.

Keep up to date with Blood Cancer Discovery

Follow @BCD_AACR

About the Journal

Editors-in-Chief

Impact Factor

Featured Articles

Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel

HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion

A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML

Trending - Altmetric

Keep up to date with Blood Cancer Discovery

AACR Journals

This Feature Is Available To Subscribers Only